Document is current
Any future updates will be listed below
-
Authors
Kato, Mamoru https://orcid.org/0000-0002-8485-8316
Nakamura, Hiromi
Nagai, Momoko
Kubo, Takashi
Elzawahry, Asmaa
Totoki, Yasushi
Tanabe, Yuko
Furukawa, Eisaku
Miyamoto, Joe
Sakamoto, Hiromi
Matsumoto, Shingo
Sunami, Kuniko
Arai, Yasuhito
Suzuki, Yutaka
Yoshida, Teruhiko
Tsuchihara, Katsuya
Tamura, Kenji
Yamamoto, Noboru
Ichikawa, Hitoshi
Kohno, Takashi
Shibata, Tatsuhiro
-
Funding
Funding for this research was provided by:
Takeda Science Foundation
Japan Agency for Medical Research and Development (15ck0106012h0002, 15ck0106012h0002, 15ck0106117h0002)
CREST-JST (14531766)
National Cancer Center Research and Development Funds (24-A-1, 24-A-1, 24-A-1, 25-A-6, 25-A-6, 26-A-3, 26-A-3, 27-A-1, 27-A-1)
- License Information
-
More Information
Article History
Received: 7 September 2017
Accepted: 7 May 2018
First Online: 7 June 2018
Ethics approval and consent to participate
: The study was approved by the Institutional Review Boards of the National Cancer Center. All the patients provided written informed consent for the gene analysis and the patients consented to participate in the study. Research was conducted in accordance with the principles of the Declaration of Helsinki.
: NY received grants from Astellas, Bayer, Boehringer Ingelheim, Chugai, Daiichi-Sankyo, Eisai, Kyowa-Hakko Kirin, Lilly Japan, Novartis, Pfizer, Quintiles, Taiho, and Takeda, and honoraria from AstraZeneca, BMS, Chugai, Lilly Japan, Ono, and Pfizer. The remaining authors declare that they have no competing interests.
